Some observations on the central pharmacological actions of noradnamine, a proposed depressive catabolite of noradrenaline.
D000255:Adenosine Triphosphate / Q000032:analysis; D000641:Ammonia / Q000032:analysis; D000758:Anesthesia; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects*; D002552:Cerebral Ventricles; D003243:Consciousness / Q000187:drug effects; D003986:Dibenzocycloheptenes / Q000494:pharmacology*; D005260:Female; D005947:Glucose / Q000032:analysis; D005973:Glutamine / Q000032:analysis; D006003:Glycogen / Q000032:analysis; D007267:Injections; D007773:Lactates / Q000032:analysis; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000378:metabolism*; D010424:Pentobarbital / Q000494:pharmacology; D010710:Phosphates / Q000032:analysis; D051381:Rats
D003986:Dibenzocycloheptenes; D007773:Lactates; D010710:Phosphates; D005973:Glutamine; D000641:Ammonia; D000255:Adenosine Triphosphate; D006003:Glycogen; D010424:Pentobarbital; D005947:Glucose; D009638:Norepinephrine